Abstract
Previous studies in cultured, polarized Madin-Darby canine kidney II (MDCKII) renal epithelial cells have demonstrated that the apical steady-state localization and delivery of the A1 adenosine receptor is modified by disruption of the microtubule network with colchicine, whereas the basolateral localization and trafficking of the α2-adrenergic receptors (α2AR) are not; instead, the binding capacity of the α2BAR, but not α2AAR or α2CAR subtypes, is increased in a time-dependent fashion. The present studies explore the molecular basis for this α2BAR subtype-selective phenomenon. Colchicine selectively increased α2BAR density at the cell surface, as determined by confocal microscopy, receptor binding, and surface biotinylation studies. The colchicine-induced increase in the functional density of the α2BAR requires the third intracellular loop because the α2BAR loop deletion (α2BAR▵i3) mutant did not show an increased receptor density after colchicine treatment. Furthermore, the colchicine-mediated increase in α2BAR density is manifest only in polarized cells because colchicine treatment of nonpolarized MDCKII renal epithelial cells as well as simian kidney COSM6 and human embryonic kidney HEK293 cells did not effect an increase in α2BAR density. Colchicine-dependent increases in α2BAR density did not depend on functional coupling to G proteins, however, because pretreatment with pertussis toxin did not eliminate the effect of colchicine. These data indicate that microtubule-dependent regulation of α2BAR density at the basolateral surface of polarized MDCKII cells requires the third intracellular loop of α2BAR but not functional α2BAR-G protein coupling.
Footnotes
-
Send reprint requests to: Lee E. Limbird, Ph.D., Department of Pharmacology, Vanderbilt University Medical Center, D 3300 MCN, Nashville, TN 37232-6600. E-mail:lee.limbird{at}mcmail.vanderbilt.edu
-
↵1 Current address: Department of Biochemistry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78284-7760.
- Abbreviations:
- GPCR
- G protein-coupled receptor
- MDCK
- Madin-Darby canine kidney
- AR
- adrenergic receptor
- A1AdoR
- A1 adenosine receptor
- HA
- hemagglutinin
- HEK
- human embryonic kidney
- DMEM
- Dulbecco's modified Eagle's medium
- [125I]PIC
- p-[125I]iodoclonidine
- MAP
- mitogen-activated protein
- Received June 15, 1999.
- Accepted October 7, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|